Literature DB >> 17990336

Prevalence of down syndrome among children and adolescents in metropolitan Atlanta.

Lilah M Besser1, Mikyong Shin, James E Kucik, Adolfo Correa.   

Abstract

BACKGROUND: Down syndrome (DS) prevalence estimates beyond infancy are needed to assess health service needs among those with DS.
METHODS: Children with DS born in metropolitan Atlanta from 1979 through 2003 were ascertained from a population-based birth defects registry. Vital status through 2003 was obtained using case records, vital records, and the National Death Index. Prevalence was calculated by dividing the children surviving with DS by the population derived from U.S. Census estimates. Variations in DS prevalence by race, heart defects, age, birth cohort, and time period were examined using Poisson regression.
RESULTS: In metropolitan Atlanta in 2003, there were 67 livebirths with DS (13.0 per 10,000 livebirths) and 738 0- to 19-year-olds surviving with DS (8.3 per 10,000 population). Over time, births to mothers 35 years and older and DS birth prevalence increased. Birth prevalence was higher among Whites, did not vary by sex, and was higher for infants without heart defects. DS prevalence among 0- to 14-year-olds increased over time (p < .05). Within each 5 year birth cohort, prevalence decreased with age: this decrease was greater among Blacks than among Whites and among children with heart defects than among children without heart defects.
CONCLUSIONS: DS prevalence increased among livebirths and among young children. Further studies are warranted to determine whether health services are meeting the needs of an increasing number of children with DS.

Entities:  

Mesh:

Year:  2007        PMID: 17990336     DOI: 10.1002/bdra.20404

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  7 in total

1.  Current estimate of Down Syndrome population prevalence in the United States.

Authors:  Angela P Presson; Ginger Partyka; Kristin M Jensen; Owen J Devine; Sonja A Rasmussen; Linda L McCabe; Edward R B McCabe
Journal:  J Pediatr       Date:  2013-07-23       Impact factor: 4.406

2.  Down's syndrome in diabetic patients aged <20 years: an analysis of metabolic status, glycaemic control and autoimmunity in comparison with type 1 diabetes.

Authors:  T R Rohrer; P Hennes; A Thon; A Dost; M Grabert; B Rami; S Wiegand; R W Holl
Journal:  Diabetologia       Date:  2010-02-26       Impact factor: 10.122

3.  Needs and challenges of daily life for people with Down syndrome residing in the city of Rome, Italy.

Authors:  M Bertoli; G Biasini; M T Calignano; G Celani; G De Grossi; M C Digilio; C C Fermariello; G Loffredo; F Luchino; A Marchese; S Mazotti; B Menghi; C Razzano; C Tiano; A Zambon Hobart; G Zampino; G Zuccalà
Journal:  J Intellect Disabil Res       Date:  2011-06-13

4.  Out-of-pocket expenditures and care time for children with Down Syndrome: A single-hospital study in Mexico City.

Authors:  Silvia Martínez-Valverde; Guillermo Salinas-Escudero; Constanza García-Delgado; Juan Garduño-Espinosa; Verónica F Morán-Barroso; Víctor Granados-García; Ma Teresa Tiro-Sánchez; Filiberto Toledano-Toledano; Ma Vanessa Aldaz-Rodríguez
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

5.  Prenatal exposure to tetrachloroethylene-contaminated drinking water and the risk of congenital anomalies: a retrospective cohort study.

Authors:  Ann Aschengrau; Janice M Weinberg; Patricia A Janulewicz; Lisa G Gallagher; Michael R Winter; Veronica M Vieira; Thomas F Webster; David M Ozonoff
Journal:  Environ Health       Date:  2009-09-24       Impact factor: 5.984

Review 6.  Systemic and ocular manifestations of a patient with mosaic ARID1A-associated Coffin-Siris syndrome and review of select mosaic conditions with ophthalmic manifestations.

Authors:  Virginia Miraldi Utz; Diana S Brightman; Monica A Sandoval; Robert B Hufnagel; Howard M Saal
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-09-05       Impact factor: 3.359

7.  Evaluation of biochemical and hematological parameters in adults with Down syndrome.

Authors:  David de Gonzalo-Calvo; Isabel Barroeta; Madalina Nicoleta Nan; José Rives; Diana Garzón; María Carmona-Iragui; Bessy Benejam; Laura Videla; Susana Fernández; Miren Altuna; Sílvia Valldeneu; Rafael Blesa; Alberto Lleó; Francisco Blanco-Vaca; Juan Fortea; Mireia Tondo
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.